Matthew Sharpe

Analyst Matthew Sharpe, carries an average stock price target met ratio of 90.15% that have a potential upside of 23.18% achieved within 261 days. Previously, Matthew Sharpe worked at MORGAN STANLEY.

Matthew Sharpe’s has documented 202 price targets and ratings displayed on 13 stocks. The coverage was on Industrials, Technology, Financial Services sectors.

Most recent stock forecast was given on PL, Planet Labs PBC at 12-Jun-2023.

Wall Street Analyst Matthew Sharpe

Analyst best performing recommendations are on MAXR (MAXAR TECHNOLOGIES).
The best stock recommendation documented was for MAXR (MAXAR TECHNOLOGIES) at 12/14/2022. The price target of $42 was fulfilled within 2 days with a profit of $17.96 (74.71%) receiving and performance score of 373.54.

Average potential price target upside

• of $29.68 (11.03%) on CACI (CACI INTERNATIONAL).
• of $18.41 (23.41%) on BAH (BOOZ ALLEN HAMILTON).
• of $17 (22.1%) on SAIC (SCIENCE APPLICATIONS INTERNATIONAL CORP).